Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn the signs you’re ready to upgrade from secured to unsecured card, including credit milestones, income checks, and credit history considerations.
4,146 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Workday's Aneel Bhusri has reclaimed the CEO role and argues the 'vibe coding' threat to enterprise software is overs...
A durable capex cycle is forming around upgrading the power grid to handle AI, EV charging, and reshoring needs. Anal...
Analysts say the United States holds roughly $45 trillion in natural resources, a cushion that could delay debt press...
Citi raises AMD's price target to $460 on a $132B CPU forecast through 2030, but keeps a Neutral rating, signaling th...
Solana is often pitched as a blockchain that outpaces and underprices Ethereum. This article digs into why those adva...
AMD is riding a surge in AI-centric demand that could push its stock higher, even as it faces the same repricing pres...
As AI accelerates, a pair of blue-chip picks stands out for a decade-long hold. Learn why these two AI leaders fit th...
AMD beats just 2030’s earnings target two years ahead as AI-driven data center growth accelerates. Here's what it mea...
Growing demand for aging-in-place technology is reshaping funding options for seniors. This report explains how rever...
What if the driver of Micron’s future isn’t simply more chips, but denser memory in each chip? This article breaks do...
Apple raises hardware prices by up to 20% amid memory-cost pressures, while Amazon’s AWS sees robust cloud demand. Th...